Table 9 Literature review
Study | Procedure | Prosthesis | Date range | Diagnosis | Patient cohort | Avg FU (Yrs) | Survivorship | ||
|---|---|---|---|---|---|---|---|---|---|
Hips | Female | FU | Rate | ||||||
Amstutz et al. | HRA | Conserve Plus | 1996–2006 | Dysplasia | 103 | 78 % | 4.8 | 8 | 92 % |
McBryde et al. | HRA | Birmingham | 1997–2004 | Dysplasia | 96 | 81 % | 4.4 | 5 | 97 % |
Naal et al. | HRA | Birmingham | 2002–2005 | Dysplasia | 32 | 56 % | 3.6 | 5 | 94 % |
Pagnano et al. | THA | Charnley THA | 1969–1980 | Dysplasia Crowe 2 | 145 | 82 % | 14 | 7 12 | 73 % 56 % |
Numair et al. | THA | Charnley THA | 1965–1987 | Dysplasia Crowe 1–3 | 136 | 63 % | -- | 10 | 98 % |
Linde et al. | THA | Charnley THA | -- | Dysplasia | 129 | -- | -- | 5 10 | 93 % 89 % |
Millis et al. | Bernese Osteotomy | -- | 1991–1998 | Dysplasia | 135 | 86 % | 9 | 5 10 | 96 % 84 % |
Adelani et al. | Revision THA | -Varies- | 1996–2006 | <55 years old | 103 | 66 % | 6.7 | 6.7 | 69 % |
Current Study Group 1 | HRA | Corin Hybrid, Biomet ReCap™ Hybrid | 2001–2008 | Dysplasia | 121 | 71 % | 6.4 | 7 12 | 90 % 86 % |
Current Study Group 2 | HRA | Biomet ReCap™ Uncemented | 2008–2013 | Dysplasia | 242 | 74 % | 2.6 | 7 | 99 % |